From Name:
From Email:
To Name:
To Email:

Optional Message:

Study: Age, medications play role in post-transplant cancer rate

from By Karen Zabel

Organ transplant recipients regularly receive immunosuppressive drugs to help minimize the risk of rejection, but those drugs come with significant risks of their own, including leaving patients open to predatory infections and even certain types of cancer. Now, a new study suggests the type of immunosuppressant drug used as well as other factors may help predict those risks and possibly reduce them. The study was presented at the 2014 World Transplant Congress in San Francisco. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063